Top Ten Common Prejudices About Polyethylene Naphthalate Market.

From USD 3.29 billion in 2015 to USD 4.52 billion in 2020, the global HPV testing and Pap test market is expected to grow at a CAGR of 6.6 percent. Cervical cancer is the second most frequent cancer in women, coming in second only to breast cancer. Cervical cancer is caused by HPV, a sexually transmitted virus that has been scientifically confirmed to be the primary cause. Around 90% of all anal and cervical cancers, as well as 70% of vaginal and vulvar cancers, are caused by HPV. Cervical cancer is most commonly detected via Pap testing. Microscopic examination of specimens is one of these tests. However, these tests are unable to detect all genotypes that cause HPV infections and may result in a significant increase in the risk of infection.
Cervical cancer is the fourth most common type of cancer in the world, and it is the leading cause of mortality in women (Source: Global Cancer Facts and figures). In 2012, 527,624 new instances of cervical cancer were reported worldwide, with 265,653 women dying as a result of the disease. By 2020, this number is predicted to rise to 609,270 new cases and 315,727 fatalities. (Image courtesy of Globocan, 2012). Each year, around 26,000 new malignancies caused by HPV are diagnosed, 18,000 in females and 8,000 in males (Source: CDC). As the number of cervical cancer cases rises, new, more technologically advanced, and less expensive screening methods are required.
On the basis of test types, application, end user, and region, define, describe, and segment the global HPV testing and Pap test market.
To give extensive information on the key variables affecting the market's growth (drivers, restraints, opportunities, and industry-specific challenges)
To examine specific micromarkets in terms of growth patterns, prospects, and contributions to the worldwide HPV testing and Pap test market.
To give details of the competitive landscape for market players and to examine market opportunities for stakeholders.
To forecast the size of market segments in four major regional segments: North America, Europe, Asia, and the Middle East.
To validate the size of the global HPV testing and Pap test market and estimate the size of several other dependent submarkets, top-down and bottom-up methodologies were utilised. Secondary research was used to identify major market players, and primary and secondary research was used to investigate their market presence. The study of annual and financial reports of top market players, presentations, websites, and press releases of top market players, news articles, journals; and paid databases, white papers, medical journals, certified publications, articles from recognised authors, directories, and databases such as the American Cancer Society (ACS), American Societete de Cancer (ASC), American Societe de Cancer (ASC), American Societe de Cancer (ASC), American Societe de Cancer (ASC), American Societe de
Comments
Post a Comment